ADORA3
Adenosine receptor A3
As of the edition of 20 October 2026, ADORA3 (adenosine receptor A3, UniProt P0DMS8) has 6 drugs tested at it and 16 companies on the list, 0 on route A and 4 on route B.
Sources: UniProt, ClinicalTrials.gov, ChEMBL, FDA Orange Book and Purple Book, Pharos.
The protein
- UniProt
- P0DMS8
- How well studied
- Chemical tools exist; no approved drug acts on it
- Where it sits in the cell
- At a membrane
- Solved structures
- 5
- Disease areas
- Lungs and airways; Heart and blood vessels; Nervous system; Urinary and reproductive; Immune system; Nutrition and metabolism; Pregnancy and women's health; Mental health
- Registered trials of its drugs
- 443
Drugs at this target
| Status | Count |
|---|---|
| Marketed | 4 |
| Active | 2 |
| Total | 6 |
| Drug | Status | Furthest phase | US protection |
|---|---|---|---|
| Caffeine | Marketed | Phase 4 | none listed |
| Theophylline anhydrous | Marketed | Phase 4 | none listed |
| Adenosine | Marketed | Phase 4 | none listed |
| Piclidenoson | Active | Phase 3 | none listed |
| Namodenoson | Active | Phase 3 | none listed |
| Theophylline glycinate | Marketed | No phase stated | none listed |
6 of 6 drugs, the most tested first.
Companies at this target
| Where the company stands | Companies |
|---|---|
| Route B | 4 |
| Engaged | 4 |
| Undetermined | 8 |
| Total on the list | 16 |
| Company | Route |
|---|---|
| Sanofi | Route B |
| Aralez Pharmaceuticals | Route B |
| Nobelpharma | Route B |
The other 13 companies at ADORA3
In the product16 companies in all; 13 are not named here, and no score is.
See the 16 companies at ADORA3, ranked, with the facts behind eachRequest access. Nothing is shown until you do.